Modulation of cis-diamminedichloroplatinum (II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells

被引:38
作者
Marverti, G
Andrews, PA
Piccinini, G
Ghiaroni, S
Barbieri, D
Moruzzi, MS
机构
[1] SEZ CHIM BIOL,I-41100 MODENA,ITALY
[2] SEZ PATOL GEN,I-41100 MODENA,ITALY
[3] GEORGETOWN UNIV,DEPT PHARMACOL,WASHINGTON,DC 20007
关键词
cisplatin; drug resistance; drug transport; cell membrane permeability; polyamines;
D O I
10.1016/S0959-8049(96)00507-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effect of spermine (Sp), a natural polycationic amine, on cisplatin (CDDP) sensitivity and accumulation of a human ovarian CDDP-sensitive cell line (2008) and its resistant variant (C13*) was investigated. Survival was also studied. The C13* cells were approximately 20-fold resistant to CDDP, yet were found to be lust as sensitive to Sp as 2008 cells. When Sp was concurrently added with CDDP to the colony-forming assay, the IC50 dose was approximately 3-fold lower than that of CDDP alone. This decrease was the result of a synergistic interaction, as assessed by median effect analysis. The incubation of cells with the approximate IC50 dose of Sp for 1-8 h indicated that this synergism could be due to stimulation of CDDP accumulation, showing maximal uptake after 4 h of Sp exposure. This stimulation may be the result of a modulation of cellular membrane permeability by Sp, as assessed by the accumulation of [H-3]mannitol. Exposure to Sp concentrations active on CDDP uptake also significantly increased [H-3]mannitol accumulation in both cell lines. The triamine spermidine (Spd) did not significantly affect either the sensitivity of the two cell lines or CDDP and [H-3]mannitol accumulation. These results suggest that Sp is a positive modulator of CDDP uptake, and thus of its cytotoxicity, even in resistant cells, where the phenotype is partly due to a CDDP accumulation defect. (C) 1997 Published by Elsevier Science Ltd.
引用
收藏
页码:669 / 675
页数:7
相关论文
共 31 条
[21]   SHORT-TERM CIS-DIAMMINEDICHLOROPLATINUM(II) ACCUMULATION IN SENSITIVE AND RESISTANT HUMAN OVARIAN-CARCINOMA CELLS [J].
MANN, SC ;
ANDREWS, PA ;
HOWELL, SB .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (04) :236-240
[22]  
Marverti G, 1996, CLIN CANCER RES, V2, P991
[23]  
MELVIN MAL, 1980, POLYAMINES BIOMEDICA, P363
[24]  
OREDSSON SM, 1982, CANCER RES, V42, P1296
[25]   RECENT ADVANCES IN THE BIOCHEMISTRY OF POLYAMINES IN EUKARYOTES [J].
PEGG, AE .
BIOCHEMICAL JOURNAL, 1986, 234 (02) :249-262
[27]   POLYAMINES AS MODULATORS OF MEMBRANE-FUSION - AGGREGATION AND FUSION OF LIPOSOMES [J].
SCHUBER, F ;
HONG, KL ;
DUZGUNES, N ;
PAPAHADJOPOULOS, D .
BIOCHEMISTRY, 1983, 22 (26) :6134-6140
[28]  
SCHUBER F, 1989, BIOCHEM J, V260, P1
[29]   DETERMINATION OF DI-AND POLYAMINES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC SEPARATION OF THEIR 5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL DERIVATIVES [J].
SEILER, N ;
KNODGEN, B ;
EISENBEISS, F .
JOURNAL OF CHROMATOGRAPHY, 1978, 145 (01) :29-39
[30]   COMPARATIVE EFFECTS OF MONOAMINE OXIDASE INHIBITORS ON MONOAMINE OXIDASE AND DIAMINE OXIDASE [J].
SHORE, PA ;
COHN, VH .
BIOCHEMICAL PHARMACOLOGY, 1960, 5 (1-2) :91-95